FUJIFILM Cellular Dynamics Inc. Launches New Product iCell Microglia, an iPSC-Derived Neural Cell Type

hiPSC-derived microglia are utilized with the aim of advancing research to fulfill unmet medical needs for patients with neurodegenerative diseases MADISON, Wis., January 08, 2019 — FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and tissue-specific cells differentiated from iPSCs, has announced the launch of its... Read more

Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business

January 07, 2019 Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250 Billion Global Biopharmaceuticals Market SOUTH EASTON, MA / ACCESSWIRE / January 7, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of enabling high pressure-based instruments, consumables,... Read more

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

January 07, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its... Read more

QIAGEN to develop QuantiFERON®-TB Access as a new test for low-resource, high-burden regions in global fight against TB

Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to develop a proprietary new version of a QuantiFERON®-based tuberculosis (TB) test dedicated and tailored to the needs of low-resource regions with a high disease burden of TB. The new testing solution, QuantiFERON®-TB Access (QFT®... Read more

QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs

Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAcube Connect, which marks the next generation of QIAGEN’s widely used QIAcube instrument and is designed to bring the benefits of automated sample processing solution to a new level. QIAcube Connect offers greatly enhanced... Read more

QIAGEN unveils plans for next-generation digital PCR systems

Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR or dPCR), one of the fastest-growing molecular testing applications in the life sciences industry. QIAGEN expects to launch a fully integrated... Read more

Barben Analytical Launches OXYvisor™ Next-Generation Process Oxygen Analyzer

Friday, January 4, 2019 JOIN THE CONVERSATION CARSON CITY, NV – Barben Analytical, a leader in pH/ORP, oxygen and conductivity measurement products, has introduced OXYvisor, its second-generation process oxygen analyzer, which optically measures oxygen in either the gas or liquid phase. In terms of performance, OXYvisor has no equal in the marketplace for trace level... Read more

BioTek Announces New Epoch™ 2 Microplate Spectrophotometer

January 2, 2019 BioTek Instruments introduces their next generation Epoch™ 2 Microplate Spectrophotometer; with added features that enable multiple conveniences for performing absorbance measurements. Epoch 2 now includes monochromator-based individual wavelength selection or wavelength scanning from 200-999 nm to accommodate an extensive range of assays, including nucleic acid and protein quantification, ELISA, microbial growth, endotoxin, ROS assays... Read more

BD Completes Molecular Portfolio for GI Infection With New Viral Panel

FRANKLIN LAKES, N.J., Dec. 20, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX™ enteric viral panel, a molecular diagnostic test for the direct qualitative detection and differentiation of enteric viral pathogens that cause... Read more

Eppendorf CryoCube® F740 ULT freezers now all-green

19.12.2018 Hamburg, December 2018 Eppendorf reached a further milestone of sustainability by focusing the flagship ULT freezer CryoCube F740 series on future-proof green cooling liquids only: The new F740h, the advanced F740hi, and the water-cooled F740hiw. By combining longevity and quality with sustainability aspects, the CryoCube F740h is the entry model of the CryoCube F740... Read more